Back | Next |
home / stock / mlnd / mlnd message board
Subject | By | Source | When |
---|---|---|---|
$3 or above by October. | swingingRichard | investorshub | 07/24/2020 9:56:06 PM |
* * $MLND Video Chart 06-17-2020 * * | ClayTrader | investorshub | 06/17/2020 8:40:33 PM |
$2.78 nice | wesley_ | investorshub | 06/17/2020 2:12:23 PM |
* * $MLND Video Chart 05-29-2020 * * | ClayTrader | investorshub | 05/29/2020 10:05:43 PM |
I am not out yet although I did | makingitnow | investorshub | 05/29/2020 9:28:06 PM |
it was fun, im out have a great weekend | jablome | investorshub | 05/29/2020 6:43:13 PM |
$MLND $2.23 nice | wesley_ | investorshub | 05/29/2020 3:37:46 PM |
* * $MLND Video Chart 05-01-2020 * * | ClayTrader | investorshub | 05/01/2020 9:56:12 PM |
taking off today | jablome | investorshub | 05/01/2020 2:12:32 PM |
strong buy and breakout to fill the gap soon. | aristotelisonassis | investorshub | 04/27/2020 3:58:28 PM |
Adrenal A? Welp the elite got to eat. | jablome | investorshub | 04/26/2020 3:07:50 PM |
Nevanimibe-is an investigational drug being studied for the | jablome | investorshub | 04/24/2020 8:55:22 PM |
gots some at 1.46 today | jablome | investorshub | 04/24/2020 8:19:39 PM |
This one is really funny. First bought | keekee | investorshub | 04/22/2020 5:57:21 PM |
Effective immediately, $MLND Market Makers have been | keekee | investorshub | 04/14/2020 4:45:08 PM |
Two days after I started buying at $1.48, | keekee | investorshub | 04/13/2020 11:13:18 PM |
Hope you started last week under $.1.45. That's | keekee | investorshub | 04/13/2020 11:01:33 PM |
strong buy here. | aristotelisonassis | investorshub | 04/13/2020 8:41:54 PM |
* * $MLND Video Chart 04-13-2020 * * | ClayTrader | investorshub | 04/13/2020 8:12:13 PM |
Here is why the huge drop today. | JDUB | investorshub | 04/07/2020 5:08:28 AM |
News, Short Squeeze, Breakout and More Instantly...
Millendo Therapeutics Company Name:
MLND Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (“Tempest”), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, and Mille...
Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.93, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Over the past year, Millendo Therapeutics Inc. has traded in...
Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.97, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Millendo Therapeutics Inc is a late-stage biopharmaceutical ...